IN2014MU00455A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00455A
IN2014MU00455A IN455MU2014A IN2014MU00455A IN 2014MU00455 A IN2014MU00455 A IN 2014MU00455A IN 455MU2014 A IN455MU2014 A IN 455MU2014A IN 2014MU00455 A IN2014MU00455 A IN 2014MU00455A
Authority
IN
India
Prior art keywords
preparation
present disclosure
disclosure relates
novel crystalline
dolutegravir sodium
Prior art date
Application number
Other languages
English (en)
Inventor
Ramakoteswara Rao Jetti
Satish Beeravelly
Madhu Murthy Nadella
Haribabu Nandipati
Original Assignee
Mylan Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Lab Ltd filed Critical Mylan Lab Ltd
Priority to US15/114,991 priority Critical patent/US10087193B2/en
Priority to BR112016018056A priority patent/BR112016018056A2/pt
Priority to PCT/IB2015/050841 priority patent/WO2015118460A1/en
Priority to CA2938103A priority patent/CA2938103C/en
Priority to AU2015215630A priority patent/AU2015215630B2/en
Priority to IN455MU2014 priority patent/IN2014MU00455A/en
Priority to EP15710893.7A priority patent/EP3102582A1/en
Publication of IN2014MU00455A publication Critical patent/IN2014MU00455A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IN455MU2014 2014-02-07 2015-02-04 IN2014MU00455A (en])

Priority Applications (7)

Application Number Priority Date Filing Date Title
US15/114,991 US10087193B2 (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium
BR112016018056A BR112016018056A2 (pt) 2014-02-07 2015-02-04 Formas cristalinas de dolutegravir sódico e processos para suas preparações
PCT/IB2015/050841 WO2015118460A1 (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium
CA2938103A CA2938103C (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium
AU2015215630A AU2015215630B2 (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium
IN455MU2014 IN2014MU00455A (en]) 2014-02-07 2015-02-04
EP15710893.7A EP3102582A1 (en) 2014-02-07 2015-02-04 Crystalline forms of dolutegravir sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN455MU2014 IN2014MU00455A (en]) 2014-02-07 2015-02-04

Publications (1)

Publication Number Publication Date
IN2014MU00455A true IN2014MU00455A (en]) 2015-09-25

Family

ID=53777379

Family Applications (1)

Application Number Title Priority Date Filing Date
IN455MU2014 IN2014MU00455A (en]) 2014-02-07 2015-02-04

Country Status (7)

Country Link
US (1) US10087193B2 (en])
EP (1) EP3102582A1 (en])
AU (1) AU2015215630B2 (en])
BR (1) BR112016018056A2 (en])
CA (1) CA2938103C (en])
IN (1) IN2014MU00455A (en])
WO (1) WO2015118460A1 (en])

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107074875B (zh) * 2014-07-29 2019-03-29 斯洛文尼亚莱柯制药股份有限公司 度鲁特韦钠的新水合物
ES2969437T3 (es) 2015-08-19 2024-05-20 Laurus Labs Ltd Polimorfos novedosos de dolutegravir y de sales del mismo
WO2017046131A1 (en) * 2015-09-15 2017-03-23 Ratiopharm Gmbh Processes for preparing solid state forms of dolutegravir sodium
WO2017208105A1 (en) 2016-05-30 2017-12-07 Lupin Limited Novel crystalline form of dolutegravir sodium
AU2018291076B2 (en) * 2017-06-30 2021-01-21 Janssen Sciences Ireland Unlimited Company Combination and uses and treatments thereof
US20210040116A1 (en) 2017-09-07 2021-02-11 Cipla Limited New Polymorphs of Dolutegravir Sodium
US12227518B2 (en) * 2019-02-05 2025-02-18 Msn Laboratories Private Limited, R&D Center Crystalline polymorphs of sodium (4R,12AS)-9-{[(2,4-difluorophenyl) methyl]carbamoyl}-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido [1′,2′:4,5]pyrazino[2,1-b][1,3]oxazin-7-olate and process for preparation thereof
CN114213432B (zh) * 2021-12-31 2023-02-17 瑞孚信江苏药业股份有限公司 度鲁特韦的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2527451C2 (ru) 2008-12-11 2014-08-27 Вайв Хелткер Компани Синтез карбамоилпиридоновых ингибиторов интегразы вич и промежуточных соединений
WO2013038407A1 (en) 2011-09-14 2013-03-21 Mapi Pharma Ltd. Amorphous form of dolutegravir
EP3022209B1 (en) 2013-07-17 2018-03-07 ratiopharm GmbH Dolutegravir potassium salt
WO2015019310A1 (en) * 2013-08-07 2015-02-12 Mylan Laboratories Ltd Process for the preparation of dolute-gravir and intermediates thereof

Also Published As

Publication number Publication date
BR112016018056A2 (pt) 2017-08-08
CA2938103A1 (en) 2015-08-13
EP3102582A1 (en) 2016-12-14
AU2015215630A1 (en) 2016-09-22
US20160347766A1 (en) 2016-12-01
WO2015118460A1 (en) 2015-08-13
US10087193B2 (en) 2018-10-02
AU2015215630B2 (en) 2018-08-16
CA2938103C (en) 2021-08-10

Similar Documents

Publication Publication Date Title
PH12016501763B1 (en) Multispecific antibodies
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
ZA201607573B (en) Novel compositions, uses and methods for making them
IN2014MU00455A (en])
IN2013MU00646A (en])
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
MX2017001487A (es) Sofosbuvir en forma cristalina y proceso para su preparacion.
HUE055687T2 (hu) Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
HUE054626T2 (hu) Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
IN2014CH00151A (en])
MA40447A (fr) Composition pharmaceutique orale d'isotrétinoïne
IN2013MU01113A (en])
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
IN2014CH00304A (en])
PL2964607T3 (pl) Sposób wytwarzania halogeno-n,n-dimetylobenzyloamin
TW201612142A (en) Process for preparing 3-chloro-2-vinylphenol
MX2016002186A (es) Proceso para preparar dronedarona y sales de la misma.
IN2013CH05865A (en])
IN2013MU02771A (en])
IN2013MU01966A (en])
IN2013CH00453A (en])
TW201613927A (en) Method for preparation of substituted imidazopyridazines
GB201809834D0 (en) Novel crystalline form of the thifensulfuron-methyl, process for preparation and use thereof
IN2014MU01191A (en])
IN2013MU01305A (en])